Eden Health vs Medvi: Which GLP-1 Program Is Better in 2026?

Short answer: Medvi is the better fit if you want a lower flat ongoing price plus more support around diet, coaching, and provider guidance. Eden Health is the better fit if you prefer a simple membership-based model with same-price-at-every-dose medication, all-50-state availability, and possible brand-name access when clinically appropriate.

For buyers focused on ongoing cost, Medvi’s flat $179/mo compounded injectable now undercuts Eden’s ~$198/mo all-in, because Eden charges $99/mo for medication plus a required $99/mo membership. Check Medvi first on price, then compare the final checkout total with Eden Health. If you are new to GLP-1 medications, anxious about side effects, or want help building habits around the medication, Medvi’s coaching adds value on top of the lower price.

This comparison is for cash-pay buyers deciding between two telehealth GLP-1 programs before signing up. It focuses on price, medication access, support, state availability, and the practical questions to ask before entering a card.

Eden Health vs Medvi at a glance

My recommendation

Choose Eden Health if your main question is, “Where can I get a legitimate GLP-1 program under one simple membership?” Eden’s site emphasizes upfront pricing, free shipping, same-price-at-every-dose positioning, FSA and HSA eligibility, 24/7 provider messaging, online visits, and compounded medications from state-licensed pharmacies. Just remember the $99/mo membership sits on top of the $99/mo medication.

Choose Medvi if your main question is, “Who gives me the lower ongoing price and will help me through the process?” Medvi now pairs a flat $179/mo injectable with physician guidance, care coaching, dietitian support, 24/7 support, progress tracking, and an all-in-one patient portal. That combination matters if you want both a lower monthly cost and help with side effects, nutrition, dose adjustments, and staying on track.

The tradeoff has shifted: Medvi is now the stronger value-plus-support pick, while Eden is the cleaner single-membership experience.

Pricing: Medvi now has the lower ongoing price

Pricing changes often, and both programs may use first-month promotions, dose-based pricing, or medication-specific pricing. Always confirm the final price before checkout.

Here is the practical comparison based on PeptidePub review data and provider-page checks:

If your goal is the lowest ongoing monthly price, Medvi now has the advantage with its flat $179/mo injectable. Eden’s $99 medication looks cheaper at a glance, but the required $99/mo membership pushes its all-in cost to roughly $198/mo for semaglutide and about $298/mo for tirzepatide.

Before you choose either one, ask:

1. What will I pay after the first month?
2. Does the price change as my dose increases?
3. Is medication, provider review, supplies, shipping, and follow-up included?
4. What happens if I pause, cancel, or need a medication change?
5. Will I know the pharmacy before the medication ships?

Eden’s $99 medication price can disappoint at checkout once the required $99/month membership is added. With Medvi, confirm whether you are quoted the flat $179/mo injectable or the higher-priced $249/mo tablet.

Medication options: both focus on compounded GLP-1s

Both Eden Health and Medvi operate in the online GLP-1 weight-loss space. Both may connect eligible patients with compounded semaglutide or compounded tirzepatide. Eden’s public site also discusses access to FDA-approved options such as Ozempic, Wegovy, Zepbound, and Mounjaro when clinically appropriate.

That distinction matters. FDA-approved medications such as Wegovy and Zepbound are not the same thing as compounded semaglutide or compounded tirzepatide. Compounded GLP-1 medications can be cheaper and easier to access for cash-pay buyers, but the compounded finished products are not FDA-approved.

For a deeper explanation, read PeptidePub’s compounded vs brand GLP-1 guide. If you are deciding between semaglutide and tirzepatide, PeptidePub’s tirzepatide vs semaglutide comparison explains the clinical differences.

Support: Medvi has the stronger coaching angle

This is where Medvi separates itself.

Eden’s model is more streamlined. Its public site lists 24/7 provider messaging, same-day online visits and prescriptions, free expedited shipping, FSA and HSA eligibility, and online care access. That can be plenty if you already understand GLP-1 treatment, know how to handle basic side effects, and mainly need a legitimate prescription pathway.

Medvi’s public site leans harder into support. It lists licensed medical providers, 1:1 physician guidance, free dietitian visits and care coaching with eligibility caveats, 24/7 support, fast and discreet shipping, and an all-in-one portal for progress and provider communication. PeptidePub’s Medvi review also positions it as a better fit for people who want nutrition guidance and a more hands-on program.

That support can matter because GLP-1 treatment is not just a prescription. Many people need help with nausea, constipation, protein intake, strength training, dose escalation, appetite changes, and what to do when weight loss slows.

Medvi now offers both the lower flat price and the more guided experience. Choose Eden if you specifically prefer its single-membership model or want its possible brand-name access options.

Safety and legitimacy checks

Neither Eden nor Medvi should be judged only by price. GLP-1 medications can cause side effects and require medical oversight.

The FDA warns that unapproved GLP-1 drugs used for weight loss do not go through FDA review for safety, effectiveness, or quality before marketing. FDA has also raised concerns about compounded GLP-1 products, including dosing errors, improper storage during shipping, fraudulent products, salt forms of semaglutide, and adverse-event reports involving compounded semaglutide and tirzepatide.

That does not mean every compounded GLP-1 program is unsafe. It means buyers should use a checklist.

Before using either provider, confirm:

• A licensed clinician reviews your medical history before prescribing.
• The medication requires a prescription.
• The dispensing pharmacy is state-licensed.
• The program tells you whether you are receiving brand-name or compounded medication.
• The label and dosing instructions are clear.
• You know who to contact if side effects happen.
• You understand cancellation timing before the next shipment.

Avoid any site selling “research use only” GLP-1 vials for self-treatment. That is not the same category as a prescription telehealth program.

What kind of results can you expect?

Do not choose Eden or Medvi based on before-and-after photos alone. The medication class has strong clinical evidence, but your result depends on the medication, dose, adherence, diet, activity, side effects, and whether you can stay on treatment.

In the STEP 1 trial, once-weekly semaglutide 2.4 mg plus lifestyle intervention produced about 14.9% average weight loss at 68 weeks, compared with 2.4% with placebo. In SURMOUNT-1, tirzepatide produced substantial weight loss over 72 weeks, with the 15 mg group averaging about 20.9% weight loss compared with 3.1% with placebo.

Head-to-head evidence also matters. In SURMOUNT-5, tirzepatide produced greater average weight loss than semaglutide at 72 weeks. PeptidePub’s tirzepatide guide and semaglutide guide summarize the trial data and side-effect context.

Those numbers do not guarantee your result through Eden or Medvi, especially if you are using compounded medication or a different dose. They do show why buyers compare these programs so seriously. The treatment category can work, but the provider should make access, safety, support, and cost clear.

Who should choose Eden Health?

Eden Health is the better fit if you:

• Prefer a single, simple membership model.
• Are comfortable with online intake and messaging.
• Do not need intensive coaching.
• Want same-price-at-every-dose medication.
• Want a simple prescription, medication, and shipping model.
• Prefer all-50-state availability for GLP-1 programs.
• May want brand-name options when clinically appropriate.

Start here if you prefer Eden’s membership model: check Eden Health eligibility.

Eden may not be ideal if your main goal is the lowest ongoing price or you want dietitian support and live coaching.

Who should choose Medvi?

Medvi is the better fit if you:

• Want the lower flat ongoing price.
• Are new to GLP-1 medication.
• Want help with nutrition and habits.
• Value 1:1 physician guidance.
• Want a more supportive program structure.
• Want coaching or dietitian access when available.
• Need more reassurance around side effects and dose adjustments.

Start here if you want value plus support: take the Medvi quiz.

Medvi may not be ideal if you specifically prefer Eden’s single-membership model or want brand-name access Eden may offer.

Eden Health vs Medvi: decision framework

Use this simple framework:

Medvi’s flat $179/mo injectable now beats Eden’s ~$198/mo all-in on ongoing cost, so Eden mainly makes sense if you specifically want its membership model or brand options. If the final price difference is small, choose based on support and which model you prefer.

For a broader shortlist, see PeptidePub’s online GLP-1 provider comparison, best online weight loss programs, and cheapest semaglutide online.

Bottom line

Medvi now wins on ongoing price and support; Eden wins on simplicity and its single-membership model. Medvi’s flat $179/mo injectable undercuts Eden’s ~$198/mo all-in once you add Eden’s required $99/mo membership to its $99/mo medication.

If I were choosing for a buyer who wants the lowest ongoing GLP-1 price plus coaching, I would start with Medvi. If I were choosing for someone who prefers a flat per-dose membership model or wants brand-name access, Eden Health is still a clean option.

The smartest move is to check both before paying. Compare the exact medication, first-month price, ongoing price, dose policy, pharmacy details, support model, and cancellation terms. The best GLP-1 program is not always the cheapest one. It is the one you can afford, understand, tolerate, and stick with safely.

FAQ

Is Medvi cheaper than Eden Health?

On ongoing cost, usually yes. Medvi’s flat $179/mo compounded injectable undercuts Eden’s ~$198/mo all-in, because Eden charges $99/mo for medication plus a required $99/mo membership. Eden’s tablets and tirzepatide widen the gap further. Confirm current pricing before checkout.

Is Medvi better than Eden Health?

Medvi is better if you want the lower flat price plus more coaching, dietitian-oriented support, and physician guidance. Eden is better if you prefer a simple single-membership model, same-price-at-every-dose medication, or possible brand-name access.

Do Eden and Medvi prescribe brand-name GLP-1s?

Eden’s public site discusses access to FDA-approved medications and compounded options when clinically appropriate. Medvi’s GLP-1 positioning focuses heavily on compounded GLP-1 care. In both cases, ask exactly what medication you are being prescribed before paying.

Are compounded GLP-1 medications FDA-approved?

No. FDA-approved Wegovy, Ozempic, Zepbound, and Mounjaro are different from compounded semaglutide or compounded tirzepatide. Compounded drugs can be appropriate in some situations, but the compounded finished product is not FDA-approved.

Which should I try first?

If ongoing price or support is your main concern, check Medvi first. If you specifically want Eden’s membership model or possible brand options, check Eden first. If the final quotes are close, choose based on the level of care and the model you prefer during the first three months.

Related posts

• Cheapest Semaglutide Online
• Best Online Weight Loss Programs
• Compounded vs Brand GLP-1 Guide

Sources

• PeptidePub Eden Health review and provider comparison pages, checked May 23, 2026.
• PeptidePub Medvi review and provider comparison pages, checked May 23, 2026.
• TryEden public website, checked May 23, 2026.
• Medvi public website, checked May 23, 2026.
• FDA. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
• Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
• Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
• NEJM and ACC summaries of SURMOUNT-5 tirzepatide vs semaglutide obesity data.